Literature DB >> 1881909

Evidence for a factor required for transcriptional stimulation by the chimeric acidic activator GAL-VP16 in HeLa cell extracts.

J H White1, C Brou, J Wu, N Burton, J M Egly, P Chambon.   

Abstract

We provide biochemical evidence for the existence of a transcriptional intermediary factor (TIF) in HeLa whole-cell extracts (WCE) that is distinct from the basic transcription factors and that is required for transcriptional stimulation by the chimeric acidic activator GAL-VP16. We have fractionated HeLa WCE by heparin-agarose chromatography. Of transcriptionally active fractions eluting in a step between 0.24 and 0.6 M KCl, the initial fractions are refractory to GAL-VP16 stimulation, whereas subsequent fractions are strongly stimulated by the activator. Aliquots of GAL-VP16-responsive fractions efficiently complement refractory fractions for transcriptional stimulation. Aliquots of responsive fractions are also far more efficient than those of refractory fractions in overcoming transcriptional inhibition that is brought about by high concentrations of GAL-VP16. Experiments performed with heat-treated WCE support the idea that HeLa cells contain a TIF that is essential for GAL-VP16 stimulation, but that is not required for basal transcription. Addition of recombinant yeast or human transcription factor TFIID (rTFIIDY and rTFIIDH, respectively) to a WCE heated at 48 degrees C for 15 min restores basal transcription, but in neither case is the reconstituted system activated by GAL-VP16. However, a 45 degrees C heat-treated WCE reconstituted with either rTFIIDH or rTFIIDY is stimulated by GAL-VP16, suggesting that a HeLa TIF can be selectively inactivated by heating at 48 degrees C, but not at 45 degrees C. Interestingly, a TFIID fraction partially purified from HeLa cell extracts, but not rTFIIDH, efficiently relieves transcriptional inhibition by GAL-VP16, suggesting that there may be an association between TIF(s) and TFIID and, moreover, that TIF(s) may be the direct target of the acidic domain of GAL-VP16. In summary, our results support the existence of a TIF that is not essential for basal transcription but that is required to mediate the stimulatory activity of the acidic activator GAL-VP16.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1881909      PMCID: PMC52364          DOI: 10.1073/pnas.88.17.7674

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Distinct classes of transcriptional activating domains function by different mechanisms.

Authors:  D Tasset; L Tora; C Fromental; E Scheer; P Chambon
Journal:  Cell       Date:  1990-09-21       Impact factor: 41.582

Review 2.  Commitment and activation at pol II promoters: a tail of protein-protein interactions.

Authors:  B Lewin
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

3.  Direct and selective binding of an acidic transcriptional activation domain to the TATA-box factor TFIID.

Authors:  K F Stringer; C J Ingles; J Greenblatt
Journal:  Nature       Date:  1990-06-28       Impact factor: 49.962

4.  Mechanism of transcriptional activation by Sp1: evidence for coactivators.

Authors:  B F Pugh; R Tjian
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

5.  A novel mediator between activator proteins and the RNA polymerase II transcription apparatus.

Authors:  R J Kelleher; P M Flanagan; R D Kornberg
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

6.  Selective inhibition of activated but not basal transcription by the acidic activation domain of VP16: evidence for transcriptional adaptors.

Authors:  S L Berger; W D Cress; A Cress; S J Triezenberg; L Guarente
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

Review 7.  Activators and targets.

Authors:  M Ptashne; A A Gann
Journal:  Nature       Date:  1990-07-26       Impact factor: 49.962

8.  Evidence for interaction of different eukaryotic transcriptional activators with distinct cellular targets.

Authors:  K J Martin; J W Lillie; M R Green
Journal:  Nature       Date:  1990-07-12       Impact factor: 49.962

9.  Transcription in yeast activated by a putative amphipathic alpha helix linked to a DNA binding unit.

Authors:  E Giniger; M Ptashne
Journal:  Nature       Date:  1987 Dec 17-23       Impact factor: 49.962

10.  Factors involved in specific transcription by mammalian RNA polymerase II: purification, genetic specificity, and TATA box-promoter interactions of TFIID.

Authors:  N Nakajima; M Horikoshi; R G Roeder
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

View more
  27 in total

1.  Codon optimization markedly improves doxycycline regulated gene expression in the mouse heart.

Authors:  M L Valencik; J A McDonald
Journal:  Transgenic Res       Date:  2001-06       Impact factor: 2.788

2.  The Epstein-Barr virus R transactivator (Rta) contains a complex, potent activation domain with properties different from those of VP16.

Authors:  J M Hardwick; L Tse; N Applegren; J Nicholas; M A Veliuona
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

3.  Mutations in the carboxy-terminal domain of TBP affect the synthesis of human immunodeficiency virus type 1 full-length and short transcripts similarly.

Authors:  P S Pendergrast; D Morrison; W P Tansey; N Hernandez
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

4.  Properties of initiator-associated transcription mediated by GAL4-VP16.

Authors:  C Chang; J D Gralla
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

5.  Direct activation and anti-repression functions of GAL4-VP16 use distinct molecular mechanisms.

Authors:  J G Lyons; P Chambon
Journal:  Biochem J       Date:  1995-12-15       Impact factor: 3.857

6.  Transcriptional activation by the acidic domain of Vmw65 requires the integrity of the domain and involves additional determinants distinct from those necessary for TFIIB binding.

Authors:  S Walker; R Greaves; P O'Hare
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

7.  A cell-specific factor represses stimulation of transcription in vitro by transcriptional enhancer factor 1.

Authors:  S Chaudhary; C Brou; M E Valentin; N Burton; L Tora; P Chambon; I Davidson
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

8.  Molecular cloning of an essential subunit of RNA polymerase II elongation factor SIII.

Authors:  K P Garrett; S Tan; J N Bradsher; W S Lane; J W Conaway; R C Conaway
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

9.  Transcriptional activation by herpes simplex virus type 1 VP16 in vitro and its inhibition by oligopeptides.

Authors:  T J Wu; G Monokian; D F Mark; C R Wobbe
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

10.  Purified cofactors and histone H1 mediate transcriptional regulation by CTF/NF-I.

Authors:  Y Dusserre; N Mermod
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.